欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DK/H/2546/001
药品名称Sevelamercarbonate "Viatris Pharma"
活性成分
    • sevelamer carbonate 2.4 g
剂型Powder for oral solution
上市许可持有人Mylan S.A.S. 117 Allée des Parcs 69800 Saint Priest France
参考成员国 - 产品名称Denmark (DK)
Sevelamercarbonate "Mylan"
互认成员国 - 产品名称
    • France (FR)
许可日期2016/09/15
最近更新日期2024/05/23
药物ATC编码
    • V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia
    • V03AE02 sevelamer
    • V VARIOUS
    • V03 ALL OTHER THERAPEUTIC PRODUCTS
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase